We are proud to announce that we have received the American Heart Association’s Get With The Guidelines® – Coronary Artery Disease STEMI Receiving Center Silver recognition for our commitment to providing rapid, research-based care to people experiencing a specific type of heart attack known as an ST elevation myocardial infarction (STEMI), considered more severe and life-threatening than other types of heart attacks.
Each year, more than 1.2 million people in the U.S. are hospitalized with acute coronary syndrome (ACS), according to the American Heart Association’s 2026 Heart Disease and Stroke Statistics Report. About 30% of ACS cases are classified as STEMI, caused by a complete blockage in a coronary artery.
Recognition as a STEMI Receiving Center highlights hospitals that provide around-the-clock support for patients experiencing STEMI. These facilities coordinate closely with a network of referring hospitals and emergency medical services to deliver timely, guideline-directed STEMI and NSTEMI care.
“Effective and timely care is critical for patients experiencing a STEMI heart attack. The American Heart Association’s guidelines outline specific interventions for these patients both during hospitalization and after discharge,” said Abhinav Goyal, M.D., MHS, FACC, FAHA, volunteer chair of the American Heart Association Coronary Artery Disease System of Care Advisory Group.
Each year, hospitals earn STEMI Receiving Center recognition by demonstrating a sustained commitment to treating people according to the most current, science-based guidelines for STEMI care, as outlined by the American Heart Association. Dallas Medical Center also received the American Heart Association’s Target: Type 2 Diabetes™ Honor Roll award. Target: Type 2 Diabetes aims to ensure patients with Type 2 diabetes, who might be at higher risk for complications, receive the most up-to-date, evidence-based care when hospitalized due to heart attack.
This is just another way to show we are continuing to provide exceptional care to our community.